Skip to content

Study of an Expandable Interbody Device for the Lumbar Spine

Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02075554
Acronym
CALIBER
Enrollment
58
Registered
2014-03-03
Start date
2012-07-31
Completion date
2017-02-28
Last updated
2021-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Disc Disease

Brief summary

The primary objective of this study is to evaluate the safety and efficacy of CALIBER expandable spacer for the treatment of degenerative disc disease. Radiographic outcomes, intra-operative parameters, clinical outcomes, and patient satisfaction will be obtained from patients in this 2 year follow-up clinical study.

Detailed description

Patients will be followed-up at 3weeks, 6 weeks, 3 months, 6 months, 12 and 24 months with X-rays and questionnaires to determine their satisfaction, healing, fusion and return to work status

Interventions

DEVICECALIBER

Expandable interbody spacer

Sponsors

Mt. Sinai Medical Center, Miami
CollaboratorOTHER
Carolina Neurosurgery & Spine Associates
CollaboratorOTHER
Globus Medical Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Lumbar interbody cages

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* DDD at 1 or 2 levels between L2 and S1 * Between 18 and 80 years of age * Unresponsiveness to documented non-surgical treatment modalities for a minimum of six months * Ability to provide a signed Informed Consent

Exclusion criteria

* Trauma at level(s) to be fused * Previous documentation of osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated * Immunosuppressive disorder * History of substance abuse * Any known allergy to a metal alloy

Design outcomes

Primary

MeasureTime frameDescription
Fusion and Disc Height Maintenance24 monthsInter-vertebral disc height in millimetres at 24 month follow up.
Fusion Assessment24 monthsAn assessment of the fusion status of surgically treated spinal levels.

Secondary

MeasureTime frameDescription
Patient Self AssessmentUpto 24 moOswestry Disability Index. A 10 item questionnaire with responses scored 0 to 5 and then presented as a percentage score from 0 to 100, with higher scores denoting more disability.
Visual Analog Scale for Back Pain24 monthsA visual scale from 0 to 100 in which the patient responds with their pain level by marking on the line, higher as more severe pain.

Countries

United States

Participant flow

Pre-assignment details

The protocol was approved to enroll 60 patients but only 58 patients were enrolled.

Participants by arm

ArmCount
CALIBER
1 or 2 levels of DDD between L2 and S1, treated with transforaminal interbody fusion CALIBER: Expandable interbody spacer
43
Total43

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up7
Overall StudyPhysician Decision3
Overall StudyWithdrawal by Subject5

Baseline characteristics

CharacteristicCALIBER
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
12 Participants
Age, Categorical
Between 18 and 65 years
31 Participants
Age, Continuous54 years
Region of Enrollment
United States
43 participants
Sex: Female, Male
Female
31 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 43
other
Total, other adverse events
0 / 43
serious
Total, serious adverse events
0 / 43

Outcome results

Primary

Fusion and Disc Height Maintenance

Inter-vertebral disc height in millimetres at 24 month follow up.

Time frame: 24 months

Population: Not all patients had x ray images to measure at 24 month follow up. A total of 33 surgical levels were measured from 29 patients.

ArmMeasureValue (MEAN)
CALIBERFusion and Disc Height Maintenance11.60 millimetres
Primary

Fusion Assessment

An assessment of the fusion status of surgically treated spinal levels.

Time frame: 24 months

Population: Only 29 patients were available for fusion assessment at 24 months, for a total of 33 surgical levels.

ArmMeasureValue (COUNT_OF_UNITS)
CALIBERFusion Assessment33 Surgical Levels
Secondary

Patient Self Assessment

Oswestry Disability Index. A 10 item questionnaire with responses scored 0 to 5 and then presented as a percentage score from 0 to 100, with higher scores denoting more disability.

Time frame: Upto 24 mo

Population: Not all patients completed the Oswestry Disability Index questionnaire at 24 month follow up, leaving 38 responses.

ArmMeasureValue (MEAN)
CALIBERPatient Self Assessment18.79 scores on a scale
Secondary

Visual Analog Scale for Back Pain

A visual scale from 0 to 100 in which the patient responds with their pain level by marking on the line, higher as more severe pain.

Time frame: 24 months

Population: 38 patients completed the question at 24 month follow up

ArmMeasureValue (MEAN)
CALIBERVisual Analog Scale for Back Pain10.71 score on a scale out of 100

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026